Skip to main content

Plant-derived chimeric antibodies against Toxoplasma gondii

Potential Commercialised fa-solid fa-cart-arrow-down violet
Reg. ID : 16886
Comments

Huraian

The present invention disclosed a pharmaceutical composition for treating Toxoplasma gondii infection comprising novel plant-derived chimeric antibodies. Besides, the present invention also disclosed a method of producing the novel plant-derived chimeric antibodies. The plant-derived chimeric antibodies can be generated rapidly from a phage display antibody library and expressed in plants as a cost-effective antibody production platform. These novel plant-derived chimeric antibodies are suitable for the development of plant-derived immunotherapeutic interventions against toxoplasmosis.

Contact Person/Inventor

Name Email Contact Phone
Um Centre Of Innovation And Enterprise (Umcie) umcie@um.edu.my 013-2250151 / 03-79677351

Intellectual Property

Type of IP Registration ID
1 Patent Filed PI 2018704279

Award

Award Title Award Achievement Award Year Received
0 0 0

Komen

LOG IN or REGISTER to post comments.

Star Rating

Star Rating
Masih tiada undi

Contact Form